A Diagnostic Approach to Equine Glanders in Germany


By Equine Disease Quarterly

January 10, 2016

Credit: Thinkstock
Which horse has glanders? According to the researchers' experience, clinically normal but infected (i.e., IB positive) horses do not show classic clinical signs.

Glanders, one of the oldest known zoonotic infectious diseases, is caused by the bacterium Burkholderia mallei. Infection with B. mallei may cause clinical signs in horses after an incubation time of three to five days or longer. The disease is widespread in several countries in South America, the Middle East, Asia and Africa. During the last five years, cases were reported from Afghanistan, Bahrain, Germany, Kuwait, Lebanon, Brazil, Mongolia, Myanmar, Eritrea, India, Iran, Pakistan and Russia. Notification to the World Organization for Animal Health (OIE) is compulsory for OIE member states. Impacted countries face rigorous restrictions in international trade of equids and their products for at least six months.

In 2014, after 60 years of disease freedom, Germany identified a glanders-positive horse. Glanders had been considered eradicated in Western Europe since the 1960s. This initiated an international discussion concerning adequate methods to confirm infection or disease.

A glanders case definition is not available from the OIE. Consequently, each country must implement its own regulations. For serological testing and confirmation of clinical suspicion, Germany relies on the OIE prescribed complement fixation test (CFT) in combination with the immunoblot technique. The CFT is prescribed for international trade by OIE. Unfortunately, the CFT result is influenced by many parameters, such as the bacterial strains used for antigen production—we use a certified CFT antigen (ccpro, Oberdorla, Germany); the complement and hemolytic systems (standardized components are advised to minimize intrinsic variation); and technical aspects, such as incubation time and temperature.

The highly specific immunoblot (IB) for glanders is used to exclude false positive CFT results. Validation data confirm that the IB test is only positive for infected animals. It must, however, be validated for different geographic regions. IB validation, following OIE recommendations, is an ongoing project not yet finalized at the glanders OIE reference laboratory in Germany. The 2014 case of glanders in Germany was identified by this test combination.

According to our experience, clinically normal but infected (i.e., IB positive) horses do not show classic clinical signs. Therefore, the detection of B. mallei in these horses is highly challenging. At necropsy, a thorough search for lesions especially in nasal cavity, skin, and internal organs is necessary, since they are often barely visible. All lesions and aberrant tissues must be sampled for further analysis. To investigate if a horse is infected with B. mallei, a combination of techniques is used. These include cultivation, polymerase chain reaction test (to detect B. mallei DNA), histology (to exclude other diseases), immunohistochemistry (IHC) to visualize B. mallei antigen in tissue sections, and experimental infection of guinea pigs. Finally, detection of B. mallei may still fail in a significant number of cases, because few bacteria are present in glanderous lesions. These laborious and time consuming procedures require up to seven weeks to complete before final results are available.

In Germany, serologically positive CFT results for glanders must be immediately verified by IB at least twice. Horses that test CFT positive but IB negative have to be re-tested three times at two- to three-week intervals; horses that remain negative are considered uninfected. Suspicious and outbreak populations must be re-tested at least three times in two- to three-week intervals with negative CFT results before restrictions on these populations can be lifted. Positive CFT results that have been confirmed by IB are considered as proof for B. mallei infection, even in the absence of clinical disease or detection of B. mallei. Additionally, isolation, molecular identification and/ or IHC identification of the agent in characteristic lesions constitute unambiguous proof of B. mallei infection.

This article was written by Drs. Many C. Elschner, Elisabeth Liebler-Tenorio, and Heinrich Neubauer of the Friedrich-Loeffler Institute in Germany. You may contact Elschner at mandy.elschner@fli.bund.de.

This article is from the Equine Disease Quarterly, published by the University of Kentucky College of Agriculture, Food and Environment Department of Veterinary Science and sponsored by Lloyd’s of London and its Kentucky agents. You may subscribe to this publication for free.

Login or Register Here now to post a comment

Related Aricles

EquiManagement Magazine March/April 2017 Edition

EquiManagement magazine is designed to provide business solutions to equine veterinary practitioners, vet techs and assistants, and those who work in an equine veterinary practices. This information...

Read More »

AAEVT Anesthesia One Day Event

The AAEVT will host a one-day Anesthesia CE course hosted by Animal Imaging Clinic in Irving, Texas, on April 8. The program will feature Lori Bidwell, DVM, DACVAA. The program will...

Read More »

Dr. Rick Mitchell Named AAEP Foundation Chair

Rick Mitchell, DVM, DACVSMR, co-founder in 1989 of Fairfield Equine Associates in Newtown, Conn., has been appointed chair of the AAEP Foundation.   As part-owner of Fairfield Equine, a sport...

Read More »


Keeping Up from the 2016 AAEP Convention: Effect of Dose and Diet on Omeprazole
A topic from the 2016 AAEP Convention focused on the effects of diet and dose on the duration and potency of acid suppression from administration of omeprazole used for treatment and prevention of gastric ulcer syndrome... Read More
Multiple Reports of Strangles and EHV-4 in Nevada
The Nevada Department of Agriculture (NDA) began receiving accounts of horses exposed to equine herpesvirus type-4 (EHV-4) and Streptococcus equi... Read More
Equine Herpes Virus Confirmed in Texas Horse
The Texas Animal Health Commission (TAHC) confirmed equine herpes myeloencephalopathy (EHM), the neurologic disease linked to equine herpesvirus type 1, in a Denton County barrel racing horse on... Read More
USEF Agrees to Grant Farmer/Glefke Rehearing Request
The United States Equestrian Federation Hearing Committee has granted a request for a rehearing in the case against Kelley Farmer and Larry Glefke for the presence of GABA in the horse... Read More

From Our Sponsors

Most Recent

Vision & Mission Statements for Equine Practices
Crafting mission and vision statements for your equine veterinary practice will help you, your employees and your clients understand the core values of your business. Read More
The Perfect Outdoor Exam Area
Veterinarians need to consider safety and utility in their outdoor exam areas. Read More
Veterinary Jobs in Industry
Equine practitioners who are looking for alternatives to private or group practice might find their answers in the business world. Read More
Can You Afford (Not to Do) Welfare and Charity Work
Colleagues discuss the pros and cons of equid welfare work. Read More

Most Read

Veterinarians Get a Leg Up in the War Against Equine Dermatitis
EPD is not a specific diagnosis. It is a syndrome. A term--scratches, dew poisoning, greasy heel, mud fever, foot rot, cracked heels--to describe cutaneous lesions caused... Read More
EQUIOXX (firocoxib) Tablets Receive FDA Approval
For almost 10 years, EQUIOXX (firocoxib) has been the only coxib non-steroidal anti-inflammatory drug (NSAID) approved for use in horses. Now, this once-daily treatment to control joint pain and... Read More
Madigan Foal Squeeze Procedure for Neonatal Maladjustment Syndrome
Veterinary researchers at the University of California, Davis, are teaming up with their colleagues in human medicine to investigate a troubling disorder in newborn horses and are exploring possible... Read More
FDA Issues Warning Letters for Unapproved Omeprazole Drugs Marketed for Use in Horses
The U.S. Food and Drug Administration has issued nine warning letters to companies arketing unapproved animal drugs containing omeprazole. These products have not been reviewed by the FDA for safety... Read More